CD14(+) CD15(-) HLA-DR(-) myeloid-derived suppressor cells impair antimicrobial responses in patients with acute-on-chronic liver failure.
CD14(+) CD15(-) HLA-DR(-) myeloid-derived suppressor cells impair antimicrobial responses in patients with acute-on-chronic liver failure.
复制标题
DOI:
10.1136/gutjnl-2017-314184
复制
发表时间:
2018-06
期刊:
影响因子:
24.5
通讯作者:
Antoniades CG
中科院分区:
文献类型:
--
作者:
Bernsmeier C;Triantafyllou E;Brenig R;Lebosse FJ;Singanayagam A;Patel VC;Pop OT;Khamri W;Nathwani R;Tidswell R;Weston CJ;Adams DH;Thursz MR;Wendon JA;Antoniades CG
Immune paresis in patients with acute-on-chronic liver failure (ACLF) accounts for infection susceptibility and increased mortality. Immunosuppressive mononuclear CD14+HLA-DR− myeloid-derived suppressor cells (M-MDSCs) have recently been identified to quell antimicrobial responses in immune-mediated diseases. We sought to delineate the function and derivation of M-MDSC in patients with ACLF, and explore potential targets to augment antimicrobial responses. Patients with ACLF (n=41) were compared with healthy subjects (n=25) and patients with cirrhosis (n=22) or acute liver failure (n=30). CD14+CD15−CD11b+HLA-DR− cells were identified as per definition of M-MDSC and detailed immunophenotypic analyses were performed. Suppression of T cell activation was assessed by mixed lymphocyte reaction. Assessment of innate immune function included cytokine expression in response to Toll-like receptor (TLR-2, TLR-4 and TLR-9) stimulation and phagocytosis assays using flow cytometry and live cell imaging-based techniques. Circulating CD14+CD15−CD11b+HLA-DR− M-MDSCs were markedly expanded in patients with ACLF (55% of CD14+ cells). M-MDSC displayed immunosuppressive properties, significantly decreasing T cell proliferation (p=0.01), producing less tumour necrosis factor-alpha/interleukin-6 in response to TLR stimulation (all p<0.01), and reduced bacterial uptake of Escherichia coli (p<0.001). Persistently low expression of HLA-DR during disease evolution was linked to secondary infection and 28-day mortality. Recurrent TLR-2 and TLR-4 stimulation expanded M-MDSC in vitro. By contrast, TLR-3 agonism reconstituted HLA-DR expression and innate immune function ex vivo. Immunosuppressive CD14+HLA-DR− M-MDSCs are expanded in patients with ACLF. They were depicted by suppressing T cell function, attenuated antimicrobial innate immune responses, linked to secondary infection, disease severity and prognosis. TLR-3 agonism reversed M-MDSC expansion and innate immune function and merits further evaluation as potential immunotherapeutic agent.
登录
查看更多内容
DOI:
10.1126/science.aau6977
发表时间:
2020-02-07
期刊:
Science (New York, N.Y.)
影响因子:
--
作者:
Kalluri R;LeBleu VS
通讯作者:
LeBleu VS
DOI:
10.4049/jimmunol.1000901
发表时间:
2010-08-15
期刊:
Journal of immunology (Baltimore, Md. : 1950)
影响因子:
--
作者:
Lechner MG;Liebertz DJ;Epstein AL
通讯作者:
Epstein AL
影响因子:
5.5
作者:
Bunt, Stephanie K.;Clements, Virginia K.;Ostrand-Rosenberg, Suzanne
通讯作者:
Ostrand-Rosenberg, Suzanne
DOI:
10.1093/jnci/djs436
发表时间:
2012-12-05
期刊:
Journal of the National Cancer Institute
影响因子:
--
作者:
Chew V;Tow C;Huang C;Bard-Chapeau E;Copeland NG;Jenkins NA;Weber A;Lim KH;Toh HC;Heikenwalder M;Ng IO;Nardin A;Abastado JP
通讯作者:
Abastado JP
影响因子:
16.6
作者:
Bronte V;Brandau S;Chen SH;Colombo MP;Frey AB;Greten TF;Mandruzzato S;Murray PJ;Ochoa A;Ostrand-Rosenberg S;Rodriguez PC;Sica A;Umansky V;Vonderheide RH;Gabrilovich DI
通讯作者:
Gabrilovich DI